APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI in Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI in Pharmaceutical Market Analysis and Forecast 2026-2032

5 June 2026240 pages

Choose your research edition.

Industry ResearchAI in Pharmaceutical Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Pharmaceutical Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal AI in Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Pharmaceutical Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Pharmaceutical Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global AI in Pharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI in Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI in Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI in Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI in Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI in Pharmaceutical include Cradle, Prezent, Insilico Medicine, Owkin, Inc, Certara, PathAI, Inc, Aizon, Salesforce, Inc and Aidoc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI in Pharmaceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI in Pharmaceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for AI in Pharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI in Pharmaceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI in Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI in Pharmaceutical revenue, projected growth trends, production technology, application and end-user industry.

AI in Pharmaceutical Segment by Company

Cradle

Prezent

Insilico Medicine

Owkin, Inc

Certara

PathAI, Inc

Aizon

Salesforce, Inc

Aidoc

IQVIA

ISOMORPHIC LABS

ConcertAI

Nexocode

BenevolentAI

Recursion

Iktos

XtalPi Inc

AI in Pharmaceutical Segment by Type

Cloud-Based AI Solutions

On-Premises AI Platforms

AI in Pharmaceutical Segment by Application

Drug Discovery and Design

Biomarker Identification

Clinical Trial Optimization

Manufacturing Process Optimization

Others

AI in Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI in Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI in Pharmaceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI in Pharmaceutical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI in Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-Based AI Solutions Major Player Table 3. On-Premises AI Platforms Major Player Table 4. Global AI in Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drug Discovery and Design Major Player Table 6. Biomarker Identification Major Player Table 7. Clinical Trial Optimization Major Player Table 8. Manufacturing Process Optimization Major Player Table 9. Others Major Player Table 10. AI in Pharmaceutical Industry Trends Table 11. AI in Pharmaceutical Industry Drivers Table 12. AI in Pharmaceutical Industry Opportunities and Challenges Table 13. AI in Pharmaceutical Industry Restraints Table 14. Global AI in Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global AI in Pharmaceutical Market Size by Region (2021-2026) & (US$ Million) Table 16. Global AI in Pharmaceutical Market Share by Region (2021-2026) Table 17. Global AI in Pharmaceutical Market Size by Region (2027-2032) & (US$ Million) Table 18. Global AI in Pharmaceutical Market Share by Region (2027-2032) Table 19. Global AI in Pharmaceutical Revenue by Players (US$ Million) & (2021-2026) Table 20. Global AI in Pharmaceutical Revenue Market Share by Players (2021-2026) Table 21. Global AI in Pharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI in Pharmaceutical Key Players Headquarters & Area Served Table 23. Global AI in Pharmaceutical Players, Product Type & Application Table 24. Global AI in Pharmaceutical Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global AI in Pharmaceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global AI in Pharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 29. Global AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 30. Global AI in Pharmaceutical Revenue Market Share by Type (2021-2026) Table 31. Global AI in Pharmaceutical Revenue Market Share by Type (2027-2032) Table 32. Global AI in Pharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 34. Global AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 35. Global AI in Pharmaceutical Revenue Market Share by Application (2021-2026) Table 36. Global AI in Pharmaceutical Revenue Market Share by Application (2027-2032) Table 37. Cradle Company Information Table 38. Cradle Business Overview Table 39. Cradle AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Cradle AI in Pharmaceutical Product Portfolio Table 41. Cradle Recent Development Table 42. Prezent Company Information Table 43. Prezent Business Overview Table 44. Prezent AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Prezent AI in Pharmaceutical Product Portfolio Table 46. Prezent Recent Development Table 47. Insilico Medicine Company Information Table 48. Insilico Medicine Business Overview Table 49. Insilico Medicine AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Insilico Medicine AI in Pharmaceutical Product Portfolio Table 51. Insilico Medicine Recent Development Table 52. Owkin, Inc Company Information Table 53. Owkin, Inc Business Overview Table 54. Owkin, Inc AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Owkin, Inc AI in Pharmaceutical Product Portfolio Table 56. Owkin, Inc Recent Development Table 57. Certara Company Information Table 58. Certara Business Overview Table 59. Certara AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Certara AI in Pharmaceutical Product Portfolio Table 61. Certara Recent Development Table 62. PathAI, Inc Company Information Table 63. PathAI, Inc Business Overview Table 64. PathAI, Inc AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. PathAI, Inc AI in Pharmaceutical Product Portfolio Table 66. PathAI, Inc Recent Development Table 67. Aizon Company Information Table 68. Aizon Business Overview Table 69. Aizon AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Aizon AI in Pharmaceutical Product Portfolio Table 71. Aizon Recent Development Table 72. Salesforce, Inc Company Information Table 73. Salesforce, Inc Business Overview Table 74. Salesforce, Inc AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Salesforce, Inc AI in Pharmaceutical Product Portfolio Table 76. Salesforce, Inc Recent Development Table 77. Aidoc Company Information Table 78. Aidoc Business Overview Table 79. Aidoc AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Aidoc AI in Pharmaceutical Product Portfolio Table 81. Aidoc Recent Development Table 82. IQVIA Company Information Table 83. IQVIA Business Overview Table 84. IQVIA AI in Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. IQVIA AI in Pharmaceutical Product Portfolio Table 86. IQVIA Recent Development Table 87. ISOMORPHIC LABS Company Information Table 88. ISOMORPHIC LABS Business Overview Table 89. ISOMORPHIC LABS AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. ISOMORPHIC LABS AI in Pharmaceutical Product Portfolio Table 91. ISOMORPHIC LABS Recent Development Table 92. ConcertAI Company Information Table 93. ConcertAI Business Overview Table 94. ConcertAI AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. ConcertAI AI in Pharmaceutical Product Portfolio Table 96. ConcertAI Recent Development Table 97. Nexocode Company Information Table 98. Nexocode Business Overview Table 99. Nexocode AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Nexocode AI in Pharmaceutical Product Portfolio Table 101. Nexocode Recent Development Table 102. BenevolentAI Company Information Table 103. BenevolentAI Business Overview Table 104. BenevolentAI AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. BenevolentAI AI in Pharmaceutical Product Portfolio Table 106. BenevolentAI Recent Development Table 107. Recursion Company Information Table 108. Recursion Business Overview Table 109. Recursion AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Recursion AI in Pharmaceutical Product Portfolio Table 111. Recursion Recent Development Table 112. Iktos Company Information Table 113. Iktos Business Overview Table 114. Iktos AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Iktos AI in Pharmaceutical Product Portfolio Table 116. Iktos Recent Development Table 117. XtalPi Inc Company Information Table 118. XtalPi Inc Business Overview Table 119. XtalPi Inc AI in Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. XtalPi Inc AI in Pharmaceutical Product Portfolio Table 121. XtalPi Inc Recent Development Table 122. North America AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 123. North America AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 124. North America AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 125. North America AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 126. North America AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America AI in Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 128. North America AI in Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe AI in Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe AI in Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 136. China AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 137. China AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 138. China AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 139. China AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia AI in Pharmaceutical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia AI in Pharmaceutical Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia AI in Pharmaceutical Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA AI in Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA AI in Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA AI in Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA AI in Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA AI in Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA AI in Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. AI in Pharmaceutical Image Figure 2. Global AI in Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI in Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-Based AI Solutions Image Figure 5. On-Premises AI Platforms Image Figure 6. Global AI in Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI in Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drug Discovery and Design Image Figure 9. Biomarker Identification Image Figure 10. Clinical Trial Optimization Image Figure 11. Manufacturing Process Optimization Image Figure 12. Others Image Figure 13. Global AI in Pharmaceutical Market Size (US$ Million) & (2021-2032) Figure 14. Global AI in Pharmaceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI in Pharmaceutical Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global AI in Pharmaceutical Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI in Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI in Pharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global AI in Pharmaceutical Revenue Market Share by Type (2021-2032) Figure 21. Global AI in Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI in Pharmaceutical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global AI in Pharmaceutical Revenue Market Share by Application (2021-2032) Figure 24. North America AI in Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America AI in Pharmaceutical Revenue Share by Type (2021-2032) Figure 26. North America AI in Pharmaceutical Revenue Share by Application (2021-2032) Figure 27. North America AI in Pharmaceutical Revenue Share by Country (2021-2032) Figure 28. United States AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe AI in Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe AI in Pharmaceutical Revenue Share by Type (2021-2032) Figure 33. Europe AI in Pharmaceutical Revenue Share by Application (2021-2032) Figure 34. Europe AI in Pharmaceutical Revenue Share by Country (2021-2032) Figure 35. Germany AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China AI in Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China AI in Pharmaceutical Revenue Share by Type (2021-2032) Figure 45. China AI in Pharmaceutical Revenue Share by Application (2021-2032) Figure 46. Asia AI in Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia AI in Pharmaceutical Revenue Share by Type (2021-2032) Figure 48. Asia AI in Pharmaceutical Revenue Share by Application (2021-2032) Figure 49. Asia AI in Pharmaceutical Revenue Share by Region (2021-2032) Figure 50. Japan AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA AI in Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA AI in Pharmaceutical Revenue Share by Type (2021-2032) Figure 58. SAMEA AI in Pharmaceutical Revenue Share by Application (2021-2032) Figure 59. SAMEA AI in Pharmaceutical Revenue Share by Country (2021-2032) Figure 60. Brazil AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt AI in Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based AI Solutions
  • On-Premises AI Platforms
Applications
  • Drug Discovery and Design
  • Biomarker Identification
  • Clinical Trial Optimization
  • Manufacturing Process Optimization
  • Others
Companies covered
  • Cradle
  • Prezent
  • Insilico Medicine
  • Owkin, Inc
  • Certara
  • PathAI, Inc
  • Aizon
  • Salesforce, Inc
  • Aidoc
  • IQVIA
  • ISOMORPHIC LABS
  • ConcertAI
  • Nexocode
  • BenevolentAI
  • Recursion
  • Iktos
  • XtalPi Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI in Pharmaceutical Market by Type
  3. 1.2.1 Global AI in Pharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-Based AI Solutions
  5. 1.2.3 On-Premises AI Platforms
  6. 1.3 AI in Pharmaceutical Market by Application
  7. 1.3.1 Global AI in Pharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Discovery and Design
  9. 1.3.3 Biomarker Identification
  10. 1.3.4 Clinical Trial Optimization
  11. 1.3.5 Manufacturing Process Optimization
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 AI in Pharmaceutical Market Dynamics
  1. 2.1 AI in Pharmaceutical Industry Trends
  2. 2.2 AI in Pharmaceutical Industry Drivers
  3. 2.3 AI in Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 AI in Pharmaceutical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI in Pharmaceutical Market Perspective (2021-2032)
  2. 3.2 Global AI in Pharmaceutical Growth Trends by Region
  3. 3.2.1 Global AI in Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI in Pharmaceutical Market Size by Region (2021-2026)
  5. 3.2.3 Global AI in Pharmaceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI in Pharmaceutical Revenue by Players
  2. 4.1.1 Global AI in Pharmaceutical Revenue by Players (2021-2026)
  3. 4.1.2 Global AI in Pharmaceutical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI in Pharmaceutical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI in Pharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI in Pharmaceutical Key Players Headquarters & Area Served
  7. 4.4 Global AI in Pharmaceutical Players, Product Type & Application
  8. 4.5 Global AI in Pharmaceutical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI in Pharmaceutical Market CR5 and HHI
  11. 4.6.3 2025 AI in Pharmaceutical Tier 1, Tier 2, and Tier 3
5 AI in Pharmaceutical Market Size by Type
  1. 5.1 Global AI in Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 5.3 Global AI in Pharmaceutical Revenue Market Share by Type (2021-2032)
6 AI in Pharmaceutical Market Size by Application
  1. 6.1 Global AI in Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI in Pharmaceutical Revenue by Application (2021-2032)
  3. 6.3 Global AI in Pharmaceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cradle
  2. 7.1.1 Cradle Company Information
  3. 7.1.2 Cradle Business Overview
  4. 7.1.3 Cradle AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cradle AI in Pharmaceutical Product Portfolio
  6. 7.1.5 Cradle Recent Developments
  7. 7.2 Prezent
  8. 7.2.1 Prezent Company Information
  9. 7.2.2 Prezent Business Overview
  10. 7.2.3 Prezent AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Prezent AI in Pharmaceutical Product Portfolio
  12. 7.2.5 Prezent Recent Developments
  13. 7.3 Insilico Medicine
  14. 7.3.1 Insilico Medicine Company Information
  15. 7.3.2 Insilico Medicine Business Overview
  16. 7.3.3 Insilico Medicine AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Insilico Medicine AI in Pharmaceutical Product Portfolio
  18. 7.3.5 Insilico Medicine Recent Developments
  19. 7.4 Owkin, Inc
  20. 7.4.1 Owkin, Inc Company Information
  21. 7.4.2 Owkin, Inc Business Overview
  22. 7.4.3 Owkin, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Owkin, Inc AI in Pharmaceutical Product Portfolio
  24. 7.4.5 Owkin, Inc Recent Developments
  25. 7.5 Certara
  26. 7.5.1 Certara Company Information
  27. 7.5.2 Certara Business Overview
  28. 7.5.3 Certara AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Certara AI in Pharmaceutical Product Portfolio
  30. 7.5.5 Certara Recent Developments
  31. 7.6 PathAI, Inc
  32. 7.6.1 PathAI, Inc Company Information
  33. 7.6.2 PathAI, Inc Business Overview
  34. 7.6.3 PathAI, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PathAI, Inc AI in Pharmaceutical Product Portfolio
  36. 7.6.5 PathAI, Inc Recent Developments
  37. 7.7 Aizon
  38. 7.7.1 Aizon Company Information
  39. 7.7.2 Aizon Business Overview
  40. 7.7.3 Aizon AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aizon AI in Pharmaceutical Product Portfolio
  42. 7.7.5 Aizon Recent Developments
  43. 7.8 Salesforce, Inc
  44. 7.8.1 Salesforce, Inc Company Information
  45. 7.8.2 Salesforce, Inc Business Overview
  46. 7.8.3 Salesforce, Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Salesforce, Inc AI in Pharmaceutical Product Portfolio
  48. 7.8.5 Salesforce, Inc Recent Developments
  49. 7.9 Aidoc
  50. 7.9.1 Aidoc Company Information
  51. 7.9.2 Aidoc Business Overview
  52. 7.9.3 Aidoc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Aidoc AI in Pharmaceutical Product Portfolio
  54. 7.9.5 Aidoc Recent Developments
  55. 7.10 IQVIA
  56. 7.10.1 IQVIA Company Information
  57. 7.10.2 IQVIA Business Overview
  58. 7.10.3 IQVIA AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IQVIA AI in Pharmaceutical Product Portfolio
  60. 7.10.5 IQVIA Recent Developments
  61. 7.11 ISOMORPHIC LABS
  62. 7.11.1 ISOMORPHIC LABS Company Information
  63. 7.11.2 ISOMORPHIC LABS Business Overview
  64. 7.11.3 ISOMORPHIC LABS AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ISOMORPHIC LABS AI in Pharmaceutical Product Portfolio
  66. 7.11.5 ISOMORPHIC LABS Recent Developments
  67. 7.12 ConcertAI
  68. 7.12.1 ConcertAI Company Information
  69. 7.12.2 ConcertAI Business Overview
  70. 7.12.3 ConcertAI AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ConcertAI AI in Pharmaceutical Product Portfolio
  72. 7.12.5 ConcertAI Recent Developments
  73. 7.13 Nexocode
  74. 7.13.1 Nexocode Company Information
  75. 7.13.2 Nexocode Business Overview
  76. 7.13.3 Nexocode AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Nexocode AI in Pharmaceutical Product Portfolio
  78. 7.13.5 Nexocode Recent Developments
  79. 7.14 BenevolentAI
  80. 7.14.1 BenevolentAI Company Information
  81. 7.14.2 BenevolentAI Business Overview
  82. 7.14.3 BenevolentAI AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BenevolentAI AI in Pharmaceutical Product Portfolio
  84. 7.14.5 BenevolentAI Recent Developments
  85. 7.15 Recursion
  86. 7.15.1 Recursion Company Information
  87. 7.15.2 Recursion Business Overview
  88. 7.15.3 Recursion AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Recursion AI in Pharmaceutical Product Portfolio
  90. 7.15.5 Recursion Recent Developments
  91. 7.16 Iktos
  92. 7.16.1 Iktos Company Information
  93. 7.16.2 Iktos Business Overview
  94. 7.16.3 Iktos AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Iktos AI in Pharmaceutical Product Portfolio
  96. 7.16.5 Iktos Recent Developments
  97. 7.17 XtalPi Inc
  98. 7.17.1 XtalPi Inc Company Information
  99. 7.17.2 XtalPi Inc Business Overview
  100. 7.17.3 XtalPi Inc AI in Pharmaceutical Revenue and Gross Margin (2021-2026)
  101. 7.17.4 XtalPi Inc AI in Pharmaceutical Product Portfolio
  102. 7.17.5 XtalPi Inc Recent Developments
8 North America
  1. 8.1 North America AI in Pharmaceutical Revenue (2021-2032)
  2. 8.2 North America AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 8.2.1 North America AI in Pharmaceutical Revenue by Type (2021-2026)
  4. 8.2.2 North America AI in Pharmaceutical Revenue by Type (2027-2032)
  5. 8.3 North America AI in Pharmaceutical Revenue Share by Type (2021-2032)
  6. 8.4 North America AI in Pharmaceutical Revenue by Application (2021-2032)
  7. 8.4.1 North America AI in Pharmaceutical Revenue by Application (2021-2026)
  8. 8.4.2 North America AI in Pharmaceutical Revenue by Application (2027-2032)
  9. 8.5 North America AI in Pharmaceutical Revenue Share by Application (2021-2032)
  10. 8.6 North America AI in Pharmaceutical Revenue by Country
  11. 8.6.1 North America AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI in Pharmaceutical Revenue by Country (2021-2026)
  13. 8.6.3 North America AI in Pharmaceutical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI in Pharmaceutical Revenue (2021-2032)
  2. 9.2 Europe AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI in Pharmaceutical Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI in Pharmaceutical Revenue by Type (2027-2032)
  5. 9.3 Europe AI in Pharmaceutical Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI in Pharmaceutical Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI in Pharmaceutical Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI in Pharmaceutical Revenue by Application (2027-2032)
  9. 9.5 Europe AI in Pharmaceutical Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI in Pharmaceutical Revenue by Country
  11. 9.6.1 Europe AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI in Pharmaceutical Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI in Pharmaceutical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI in Pharmaceutical Revenue (2021-2032)
  2. 10.2 China AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 10.2.1 China AI in Pharmaceutical Revenue by Type (2021-2026)
  4. 10.2.2 China AI in Pharmaceutical Revenue by Type (2027-2032)
  5. 10.3 China AI in Pharmaceutical Revenue Share by Type (2021-2032)
  6. 10.4 China AI in Pharmaceutical Revenue by Application (2021-2032)
  7. 10.4.1 China AI in Pharmaceutical Revenue by Application (2021-2026)
  8. 10.4.2 China AI in Pharmaceutical Revenue by Application (2027-2032)
  9. 10.5 China AI in Pharmaceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI in Pharmaceutical Revenue (2021-2032)
  2. 11.2 Asia AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI in Pharmaceutical Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI in Pharmaceutical Revenue by Type (2027-2032)
  5. 11.3 Asia AI in Pharmaceutical Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI in Pharmaceutical Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI in Pharmaceutical Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI in Pharmaceutical Revenue by Application (2027-2032)
  9. 11.5 Asia AI in Pharmaceutical Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI in Pharmaceutical Revenue by Country
  11. 11.6.1 Asia AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI in Pharmaceutical Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI in Pharmaceutical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI in Pharmaceutical Revenue (2021-2032)
  2. 12.2 SAMEA AI in Pharmaceutical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI in Pharmaceutical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI in Pharmaceutical Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI in Pharmaceutical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI in Pharmaceutical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI in Pharmaceutical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI in Pharmaceutical Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI in Pharmaceutical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI in Pharmaceutical Revenue by Country
  11. 12.6.1 SAMEA AI in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI in Pharmaceutical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI in Pharmaceutical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst